Last reviewed · How we verify
Serazide (BENSERAZIDE)
Serazide (generic name: BENSERAZIDE) is a drug. It is currently FDA-approved.
Serazide is a small molecule inhibitor of the enzyme aromatic-L-amino-acid decarboxylase. It is used as a DOPA decarboxylase inhibitor, and its clinical trials have studied various conditions including hormonal changes, menstrual cycle, Parkinson disease, aphasia, and beta thalassemia intermedia.
At a glance
| Generic name | BENSERAZIDE |
|---|---|
| Target | SUMO-activating enzyme, Hexokinase-2, Aromatic-L-amino-acid decarboxylase |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease
- The BENeFiTS Trial in Beta Thalassemia Intermedia (PHASE1,PHASE2)
- Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study
- Dopamine and Brain Computer Interface (EARLY_PHASE1)
- Relative Bioavailability Study of HRG2010 in Healthy Subjects (PHASE1)
- Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease (PHASE2)
- eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs. (PHASE4)
- REALITY MONITORING (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Serazide CI brief — competitive landscape report
- Serazide updates RSS · CI watch RSS
Frequently asked questions about Serazide
What is Serazide?
What is the generic name of Serazide?
What development phase is Serazide in?
What does Serazide target?
Related
- Target: All drugs targeting SUMO-activating enzyme, Hexokinase-2, Aromatic-L-amino-acid decarboxylase
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing